PAVmed Inc (PAVMZ)
USD 0.01
(1.89%)
USD 0.01
(1.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 29.08 Million USD | 1036.14% |
| 2022 | -3.1 Million USD | 95.98% |
| 2021 | -77.25 Million USD | -3264.9% |
| 2020 | -2.29 Million USD | -219.6% |
| 2019 | 1.91 Million USD | 701.58% |
| 2018 | -319.11 Thousand USD | -177.98% |
| 2017 | 409.24 Thousand USD | 169.88% |
| 2016 | -585.68 Thousand USD | 23.67% |
| 2015 | -767.26 Thousand USD | 8.56% |
| 2014 | -839.07 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 24.15 Million USD | -16.97% |
| 2024 Q2 | 24.53 Million USD | 1.59% |
| 2023 Q1 | 220 Thousand USD | 107.08% |
| 2023 FY | 29.08 Million USD | 1036.14% |
| 2023 Q4 | 29.08 Million USD | 23.78% |
| 2023 Q3 | 23.49 Million USD | 113.98% |
| 2023 Q2 | 10.98 Million USD | 4891.82% |
| 2022 Q4 | -3.1 Million USD | 82.98% |
| 2022 Q2 | -32.52 Million USD | 47.33% |
| 2022 Q1 | -61.75 Million USD | 20.07% |
| 2022 FY | -3.1 Million USD | 95.98% |
| 2022 Q3 | -18.26 Million USD | 43.86% |
| 2021 Q1 | -48.24 Million USD | -2001.31% |
| 2021 FY | -77.25 Million USD | -3264.9% |
| 2021 Q2 | -43.21 Million USD | 10.44% |
| 2021 Q4 | -77.25 Million USD | -106.9% |
| 2021 Q3 | -37.34 Million USD | 13.58% |
| 2020 Q1 | 11.93 Million USD | 521.53% |
| 2020 Q2 | 9.42 Million USD | -21.05% |
| 2020 Q3 | 12.22 Million USD | 29.8% |
| 2020 Q4 | -2.29 Million USD | -118.78% |
| 2020 FY | -2.29 Million USD | -219.6% |
| 2019 Q2 | -117.97 Thousand USD | -102.91% |
| 2019 Q1 | 4.06 Million USD | 1372.49% |
| 2019 Q4 | 1.91 Million USD | 413.29% |
| 2019 Q3 | 374.01 Thousand USD | 417.04% |
| 2019 FY | 1.91 Million USD | 701.58% |
| 2018 Q3 | -5.98 Million USD | 28.64% |
| 2018 FY | -319.11 Thousand USD | -177.98% |
| 2018 Q4 | -319.11 Thousand USD | 94.67% |
| 2018 Q2 | -8.38 Million USD | -507.47% |
| 2018 Q1 | -1.38 Million USD | -437.37% |
| 2017 FY | 409.24 Thousand USD | 169.88% |
| 2017 Q2 | -82.05 Thousand USD | 90.94% |
| 2017 Q3 | -1.52 Million USD | -1763.07% |
| 2017 Q4 | 409.24 Thousand USD | 126.77% |
| 2017 Q1 | -905.65 Thousand USD | -54.63% |
| 2016 Q2 | -3.02 Million USD | -1180.58% |
| 2016 Q1 | -236.05 Thousand USD | 69.23% |
| 2016 Q4 | -585.68 Thousand USD | 67.26% |
| 2016 FY | -585.68 Thousand USD | 23.67% |
| 2016 Q3 | -1.78 Million USD | 40.83% |
| 2015 Q2 | -521.57 Thousand USD | 28.47% |
| 2015 Q3 | -1.41 Million USD | -171.35% |
| 2015 FY | -767.26 Thousand USD | 8.56% |
| 2015 Q4 | -767.26 Thousand USD | 45.79% |
| 2015 Q1 | -729.2 Thousand USD | 0.0% |
| 2014 FY | -839.07 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -7.4% |
| BrainsWay Ltd. | -10.32 Million USD | 381.841% |
| Cerus Corporation | 84.35 Million USD | 65.518% |
| Envoy Medical, Inc. | -3.81 Million USD | 862.611% |
| electroCore, Inc. | -9.95 Million USD | 392.175% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 667.532% |
| IceCure Medical Ltd | -9.93 Million USD | 392.792% |
| Inogen, Inc. | -103.56 Million USD | 128.084% |
| OrthoPediatrics Corp. | -9.26 Million USD | 413.866% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 898.846% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 322.081% |
| MaxCyte, Inc. | -27.76 Million USD | 204.765% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 666.086% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 5151.696% |
| Orthofix Medical Inc. | 96.44 Million USD | 69.841% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 271.71% |
| RxSight, Inc. | -6.68 Million USD | 535.419% |
| Sight Sciences, Inc. | -102.71 Million USD | 128.317% |
| SI-BONE, Inc. | 5.72 Million USD | -408.408% |
| TELA Bio, Inc. | -3.94 Million USD | 836.541% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 49.258% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -8163.068% |
| Acutus Medical, Inc. | 12.27 Million USD | -136.876% |
| Talis Biomedical Corporation | -57.06 Million USD | 150.971% |
| Spectral AI, Inc. | -3.5 Million USD | 930.791% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 160.562% |
| CVRx, Inc. | -59.95 Million USD | 148.512% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -1365.921% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -2176.546% |
| Bioventus Inc. | 372.51 Million USD | 92.192% |
| Venus Concept Inc. | 74.3 Million USD | 60.854% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 385.661% |
| LivaNova PLC | 62.53 Million USD | 53.486% |
| 908 Devices Inc. | -115.09 Million USD | 125.271% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 90.931% |
| Nemaura Medical Inc. | 9.92 Million USD | -193.057% |
| NeuroPace, Inc. | 54.33 Million USD | 46.471% |
| LENSAR, Inc. | -18.31 Million USD | 258.836% |
| Apyx Medical Corporation | -5.15 Million USD | 664.667% |
| Cutera, Inc. | 288.3 Million USD | 89.911% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -287.039% |
| BioSig Technologies, Inc. | 262 Thousand USD | -11001.527% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 166.361% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 416.187% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 97.93% |
| Axonics, Inc. | -77.19 Million USD | 137.679% |
| Outset Medical, Inc. | 67.67 Million USD | 57.024% |
| IRIDEX Corporation | -4.28 Million USD | 778.312% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 116.339% |
| IRadimed Corporation | -47.71 Million USD | 160.952% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 1061.203% |
| INVO Bioscience, Inc. | 8.45 Million USD | -244.167% |
| Telesis Bio, Inc. | 32.63 Million USD | 10.875% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 1262.449% |
| Varex Imaging Corporation | 316.9 Million USD | 90.822% |
| Quipt Home Medical Corp. | 81.73 Million USD | 64.414% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1145.507% |
| Pulmonx Corporation | -42.36 Million USD | 168.664% |
| Dynatronics Corporation | 6.2 Million USD | -368.824% |
| Modular Medical, Inc. | -8.04 Million USD | 461.676% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 776.891% |
| Semler Scientific, Inc. | -57.13 Million USD | 150.912% |
| InMode Ltd. | -135.39 Million USD | 121.482% |
| Bruker Corporation | 891.3 Million USD | 96.737% |
| Cytosorbents Corporation | 4.18 Million USD | -595.502% |
| DexCom, Inc. | 2.02 Billion USD | 98.566% |
| Align Technology, Inc. | -840.47 Million USD | 103.461% |
| Viveve Medical, Inc. | -13.81 Million USD | 310.57% |
| ZimVie Inc. | 450.41 Million USD | 93.542% |
| Movano Inc. | -5.86 Million USD | 595.84% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 121.632% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 5151.696% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -1365.921% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 91.848% |
| Profound Medical Corp. | -18.17 Million USD | 260.002% |
| Insulet Corporation | 798.1 Million USD | 96.356% |
| enVVeno Medical Corporation | -2.21 Million USD | 1411.362% |
| Surmodics, Inc. | -12.01 Million USD | 342.101% |
| iCAD, Inc. | -21.2 Million USD | 237.14% |
| Nuwellis, Inc. | -2.81 Million USD | 1131.784% |
| Biotricity, Inc. | 23.09 Million USD | -25.953% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 68.942% |
| Aethlon Medical, Inc. | -4.5 Million USD | 746.117% |
| InspireMD, Inc. | -8.04 Million USD | 461.541% |
| PAVmed Inc. | 29.08 Million USD | 0.0% |
| BIOLASE, Inc. | 11.34 Million USD | -156.4% |
| Beyond Air, Inc. | 6.22 Million USD | -366.945% |
| FONAR Corporation | -14.66 Million USD | 298.332% |
| AxoGen, Inc. | 32.26 Million USD | 9.856% |
| Vivani Medical, Inc. | 42 Thousand USD | -69152.381% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 372.903% |
| Inari Medical, Inc. | -7.16 Million USD | 506.172% |
| UFP Technologies, Inc. | 40.77 Million USD | 28.665% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -847.852% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 709.602% |
| Tenon Medical, Inc. | -1.25 Million USD | 2417.61% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 482.409% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 343.881% |
| AdaptHealth Corp. | 2.21 Billion USD | 98.688% |
| Sintx Technologies, Inc. | 905 Thousand USD | -3113.923% |
| NanoVibronix, Inc. | -3.27 Million USD | 987.309% |
| Quanterix Corporation | -132.95 Million USD | 121.876% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1145.507% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 230.051% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 96.141% |
| TransMedics Group, Inc. | 121.13 Million USD | 75.989% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 211.1% |
| NeuroMetrix, Inc. | -1.49 Million USD | 2050.68% |
| Hyperfine, Inc. | -75.61 Million USD | 138.464% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 80.888% |
| Biomerica, Inc. | -3.38 Million USD | 959.261% |
| Bone Biologics Corporation | -3.02 Million USD | 1061.022% |
| AVITA Medical, Inc. | -26.23 Million USD | 210.881% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 1682.127% |
| Silk Road Medical, Inc | 64.42 Million USD | 54.852% |